Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.
Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Günthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Müllhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY; Swiss Hepatitis C Cohort Study; Swiss HIV Cohort Study. Rauch A, et al. Among authors: borovicka j. Gastroenterology. 2010 Apr;138(4):1338-45, 1345.e1-7. doi: 10.1053/j.gastro.2009.12.056. Epub 2010 Jan 11. Gastroenterology. 2010. PMID: 20060832
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial.
Helbling B, Stamenic I, Viani F, Gonvers JJ, Dufour JF, Reichen J, Cathomas G, Steuerwald M, Borovicka J, Sagmeister M, Renner EL; Investigators of the Swiss Association for the Study of the Liver. Helbling B, et al. Among authors: borovicka j. Hepatology. 2002 Feb;35(2):447-54. doi: 10.1053/jhep.2002.31168. Hepatology. 2002. PMID: 11826422 Clinical Trial.
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C.
August-Jörg BS, Borovicka J, Dufour JF, Gonvers JJ, Henz S, Hermann R, Meyenberger C, Weitz M, Renner EL; Swiss Association for the Study of the Liver. August-Jörg BS, et al. Among authors: borovicka j. Swiss Med Wkly. 2003 Aug 23;133(33-34):455-60. doi: 10.4414/smw.2003.10300. Swiss Med Wkly. 2003. PMID: 14625812 Free article. Clinical Trial.
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis.
Meyer-Wyss B, Rich P, Egger H, Helbling B, Müllhaupt B, Rammert C, Gonvers JJ, Oneta C, Criblez D, Rossi L, Borovicka J, Meyenberger C, Arn M, Renner EL; Swiss Association for the Study of the Liver (SASL). Meyer-Wyss B, et al. Among authors: borovicka j. J Viral Hepat. 2006 Jul;13(7):457-65. doi: 10.1111/j.1365-2893.2005.00709.x. J Viral Hepat. 2006. PMID: 16792539 Clinical Trial.
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin.
Helbling B, Jochum W, Stamenic I, Knöpfli M, Cerny A, Borovicka J, Gonvers JJ, Wilhelmi M, Dinges S, Müllhaupt B, Esteban A, Meyer-Wyss B, Renner EL; Swiss Association for the Study of the Liver (SASL). Helbling B, et al. Among authors: borovicka j. J Viral Hepat. 2006 Nov;13(11):762-9. doi: 10.1111/j.1365-2893.2006.00753.x. J Viral Hepat. 2006. PMID: 17052276 Clinical Trial.
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Ciuffreda D, Comte D, Cavassini M, Giostra E, Bühler L, Perruchoud M, Heim MH, Battegay M, Genné D, Mulhaupt B, Malinverni R, Oneta C, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers JJ, Pantaleo G, Dutoit V. Ciuffreda D, et al. Among authors: borovicka j. Eur J Immunol. 2008 Oct;38(10):2665-77. doi: 10.1002/eji.200838336. Eur J Immunol. 2008. PMID: 18958874 Free article.
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.
Bochud PY, Cai T, Overbeck K, Bochud M, Dufour JF, Müllhaupt B, Borovicka J, Heim M, Moradpour D, Cerny A, Malinverni R, Francioli P, Negro F; Swiss Hepatitis C Cohort Study Group. Bochud PY, et al. Among authors: borovicka j. J Hepatol. 2009 Oct;51(4):655-66. doi: 10.1016/j.jhep.2009.05.016. Epub 2009 Jun 6. J Hepatol. 2009. PMID: 19665246
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study.
Gonvers JJ, Heim MH, Cavassini M, Müllhaupt B, Genné D, Bernasconi E, Borovicka J, Cerny A, Chave JP, Chuard C, Dufour F, Dutoit V, Malinverni R, Monnat M, Negro F, Troilliet N, Oneta C. Gonvers JJ, et al. Among authors: borovicka j. Swiss Med Wkly. 2010 Jul 19;140:w13055. doi: 10.4414/smw.2010.13055. eCollection 2010. Swiss Med Wkly. 2010. PMID: 20648398 Free article. Clinical Trial.
190 results